Skip to main content

Advertisement

Log in

Correlation of molecular biomarker concentrations between synovial fluid and saliva of the patients with temporomandibular disorders

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Objectives

The synovial membrane and fluid are involved in the pathogenesis of temporomandibular joint (TMJ) disorders. This study aims to assess the relationship between matrix metalloproteinase-2 (MMP-2), chemerin and prostaglandin (PGE2) levels in the synovial fluid (SF) and saliva of patients with TMJ disorder regarding their role in inflammation and the value of being a candidate for predictive biomarkers in the disease. Also, it is aimed to find out whether chemerin’s main function triggers the formation inflammatory cytokine markers in the associated area.

Materials and methods

Thirty-two samples of SF and saliva were obtained from patients with disc displacement without reduction with limited opening (DDWORwLO). Mann-Whitney-U test was used for the comparisons of the biomarker levels in SF and saliva. The correlation between chemerin and BMI (Body Mass Index) is analyzed by non-parametric Spearman’s rho correlation coefficient.

Results

For all of the three biomarkers, statistically significant differences were found between SF and saliva. An unexpectedly high level expression of chemerin was observed in SF. A statistically significant, positive correlation was observed between PGE2 -MMP-2, and chemerin-PGE2 in saliva, chemerin and MMP-2 in SF, respectively (p = 0.031, r = 0.382 / p = 0.039, r = 0.366 / p = 0.032, r = 0.379). A positive correlation was determined between saliva and SF levels of PGE2 (p = 0.016, r = 0.421).

Conclusions

Chemerin, MMP-2, and PGE2 can play a role as an inflammatory factor for the development of TMJ disorder.

Clinical relevance

The search for molecular markers in TMJ and the inhibition of the associated molecular signaling mechanism is important to reduce joint inflammation and cartilage degradation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. McNeill C (1997) Management of temporomandibular disorders: concepts and controversies. J Prosthet Dent 77:510–522

    Article  Google Scholar 

  2. Mizui T, Ishimaru JI, Miyamoto K, Kurita K (2001) Matrix metalloproteinase-2 in synovial lavage fluid of patients with disorders of the temporomandibular joint. Br J Oral Maxillofac Surg 39:310–314

    Article  Google Scholar 

  3. Maroudas A (1976) Balance between swelling pressure and collagen tension in normal and degenerate cartilage. Nature 260:808–809

    Article  Google Scholar 

  4. Ghadially FN (1981) Structure and function of articular-cartilage. Clin Rheum Dis 7:3–28

    Google Scholar 

  5. Kubota E, Imamura H, Kubota T, Shibata T, Murakami KI (1997) Interleukin 1β and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 55:20–27

    Article  Google Scholar 

  6. Zardeneta G, Milan SB, Lee T, Schmits JP (1998) Detection and preliminary characterization of matrix metalloproteinase activity in temporomandibular joint lavage fluid. J Oral Maxillofac Surg 27:397–403

    Article  Google Scholar 

  7. Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121–125

    Article  Google Scholar 

  8. Brinckerhoff CE (1991) Joint destruction in arthritis: Metalloproteinases the spotlight. Arthritis Rheumatol 34:1073–1075

    Article  Google Scholar 

  9. Attur M, Krasnokutsky-Samuels S, Samuels J, Abramson SB (2013) Prognostic biomarkers in osteoarthritis. Curr Opin Rheumatol 25:136–144

    Article  Google Scholar 

  10. Vos LM, Kuijer R, Huddleston Slater JJ, Bulstra SK, Stegenga B (2014) Inflammation is more distinct in temporomandibular joint osteoarthritis compared to the knee joint. J Oral Maxillofac Surg 72:35–40

    Article  Google Scholar 

  11. Nishimura M, Segami N, Kaneyama K, Suzuki T, Miyamaru M (2002) Relationships between pain-related mediators and both synovitis and joint pain in patients with internal derangements and osteoarthritis of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94:328–332

    Article  Google Scholar 

  12. Ernberg M (2017) The role of molecular pain biomarkers in temporomandibular joint internal derangement. J Oral Rehabil 44:481–491

    Article  Google Scholar 

  13. Sorsa T, Tjaderhane L, Salo T (2004) Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 10:311–318

    Article  Google Scholar 

  14. Buisson-Legendre N, Smith S, March L, Jackson C (2004) Elevation of activated protein C in synovial joints in rheumatoid arthritis and its correlation with matrix metalloproteinase 2. Arthritis Rheumatol 50:2151–2156

    Article  Google Scholar 

  15. Puliti M, Momi S, Falcinelli E, Gresele P, Fetal B (2012) Contribution of matrix metalloproteinase 2 to joint destruction in group B streptococcus-induced murine arthritis. Arthritis Rheumatol 64:1089–1097

    Article  Google Scholar 

  16. Kaur J, Adya R, Tan BK, Chen J, Randeva HS (2010) Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin induced endothelial angiogenesis. Biochem Biophys Res Commun 391:1762–1768

    Article  Google Scholar 

  17. Muruganandan S, Parlee SD, Rourke JL, Ernst MC, Goralski KB, Sinal CJ (2011) Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPAR gamma) target gene that promotes mesenchymal stem cell adipogenesis. J Biol Chem 286:23982–23995

    Article  Google Scholar 

  18. Ernst MC, Issa M, Goralski KB, Sinal CJ (2010) Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology 151:1998–2007

    Article  Google Scholar 

  19. Jin CH, Yi KW, Ha YR, Shin JH, Park HT, Kim T, Hur JY (2015) Chemerin expression in the peritoneal fluid, serum, and ovarian endometrioma of women with endometriosis. Am J Reprod Immunol 74:379–386

    Article  Google Scholar 

  20. Patnaik K, Pradeep AR, Nagpal K, Karvekar S, Singh P, Raju A (2017) Human chemerin correlation in gingival crevicular fluid and tear fluid as markers of inflammation in chronic periodontitis and type-2 diabetes mellitus. J Investig Clin Dent 8:12181–12188

    Article  Google Scholar 

  21. Eisinger K, Bauer S, Schaffler A, Walter R, Neumann E, Buechler C, Müller- Ladner U, Frommer KW (2012) Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis. Exp Mol Patho 92:90–96

  22. Berg V, Sveinbjörnsson B, Bendiksen S, Brox J, Meknas K, Figenschau Y (2010) Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin 21-157. Arthritis Res Ther 12:228

    Article  Google Scholar 

  23. Conde J, Gomez R, Bianco G, Scotece M, Lear P, Dieguez C, Gomez-Reino J, Lago F, Gualillo O (2011) Expanding the adipokine network in cartilage: identification and regulation of novel factors in human and murine chondrocytes. Ann Rheum Dis 70:551–559

    Article  Google Scholar 

  24. Verma RP, Hansch C (2007) Matrix metalloproteinases (MMPs): chemical-biological functions and (Q) SARs. Bioorg Med Chem 15:2223–2268

    Article  Google Scholar 

  25. Yan W, Apweiler R, Balgley BM, Boontheung P, Bundy JL, Cargile BJ, Cole S, Fang X, Gonzalez-Begne M, Griffin TJ (2009) Systematic comparison of the human saliva and plasma proteomes. Proteomics Clin Appl 3:116–134

    Article  Google Scholar 

  26. Shoukri B, Prieto JC, Ruellas A, Yatabe M, Sugai J, Styner M, Zhu H, Huang C, Paniagua B, Aronovich S, Ashman L, Benavides E, de Dumast P, Ribera NT, Mirabel C, Michoud L, Allohaibi Z, Loshida M, Bittencourt L, Fattori L, Gomes LR, Cevidanes L (2019) Minimally invasive approach for diagnosing TMJ osteoarthritis. J Dent Res 98:1103–1111

    Article  Google Scholar 

  27. Manso H, Krug T, Sobral J, Albergaria I, Gaspar G, Ferro JM, Oliveira SA, Vicente AM (2010) Variants of the matrix Metalloproteinase-2 but not the matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke. BMC Med Genet 11:40

    Article  Google Scholar 

  28. Milward EA, Kim KJ, Szklarczyk A, Nguyen T, Melli G, Nayak M, Deshpande D, Fitzsimmons C, Hoke A, Kerr D, Griffin JW, Calabresi PA, Conant K (2008) Cleavage of myelin associated glycoprotein by matrix metalloproteinase. J Neuroimmunol 193:140–148

    Article  Google Scholar 

  29. Bobińska K, Szemraj J, Czarny P, Gałecki P (2016) Role of MMP-2, MMP-7, MMP-9 and TIMP-2 in the development of recurrent depressive disorder. J Affect Disord 205:119–129

    Article  Google Scholar 

  30. Rafni E, Yanwirasti Y, Darwin E, Rikmasari R (2017) The difference of matrix metalloproteinase-9 level in saliva between myofascial pain and disc displacement of temporomandibular joint disorders. Padjadjaran Journal of Dentistry 29

  31. Ma J, Niu DS, Wan NJ, Qin Y, Guo CJ (2015) Elevated chemerin levels in synovial fluid and synovial membrane from patients with knee osteoarthritis. Int J Clin Exp Pathol 8:13393–13398

    PubMed  PubMed Central  Google Scholar 

  32. Bas S, Finckh A, Puskas GJ, Suva D, Hoffmeyer P, Gabay C, Lübbeke A (2014) Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee. Int Orthop 38:2577–2583

    Article  Google Scholar 

  33. Huang K, Du G, Li L, Liang H, Zhang B (2012) Association of chemerin levels in synovial fluid with the severity of knee osteoarthritis. Biomarkers 17(1):16–20

    Article  Google Scholar 

  34. Ku JH, Lee CK, Joo BS, An BM, Choi SH, Wang TH, Cho HL (2009) Correlation of synovial fluid leptin concentrations with the severity of osteoarthritis. J Clin Rheumatol 28:1431–1435

    Article  Google Scholar 

  35. Karvonen-Gutierrez CA, Harlow SD, Mancuso P, Jacobson J, Mendes de Leon CF, Nan B (2013) Association of leptin levels with radiographic knee osteoarthritis among a cohort of midlife women. Arthritis Care Res 65:936–944

    Article  Google Scholar 

  36. Pfau D, Bachmann A, Lössner U, Kratzsch J, Blüher M, Stumvoll M, Fasshauer M (2010) Serum levels of the adipokine chemerin in relation to renal function. Diabetes Care 33:171–173

    Article  Google Scholar 

  37. Jentsch HFR, Arnold N, Richter V, Deschner J, Kantyka T, Eick S (2017) Salivary, gingival crevicular fluid and serum levels of ghrelin and chemerin in patients with periodontitis and overweight. J Periodontal Res 52:1050–1057

    Article  Google Scholar 

  38. Ohashi K, Parker JL, Ouchi N, Higuchi A, Vita JA, Gokce N, Pedersen AA, Kalthoff C, Tullin S, Sams A, Summer R, Walsh K (2010) Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem 285:6153–6160

    Article  Google Scholar 

  39. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, Brezillon S, Tyldesley R, Blanpain C, Detheux M, Mantovani A, Sozzani S, Vassart G, Parmentier M, Communi D (2003) Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 198:977–985

    Article  Google Scholar 

  40. Güven O, Tekin U, Salmanoğlu B, Kaymak E (2015) Tumor necrosis factor- alpha levels in the synovial fluid of patients with temporomandibular joint internal derangement. J Craniomaxillofac Surg 43:102–105

    Article  Google Scholar 

Download references

Acknowledgments

We thank Karadag O. (Department of Statistics, Graduate School of Science and Engineering, Hacettepe University) and Tasdelen B. (Department of Biostatistics and Medical Informatics, Mersin University) for their great efforts for the statistical analysis.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Deniz Yaman.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants (parents) included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yaman, D., Alpaslan, C., Akca, G. et al. Correlation of molecular biomarker concentrations between synovial fluid and saliva of the patients with temporomandibular disorders. Clin Oral Invest 24, 4455–4461 (2020). https://doi.org/10.1007/s00784-020-03310-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-020-03310-8

Keywords

Navigation